Medicinova: * Receives notice of allowance for brand-new patent covering
MN-001 and MN-002 for treatment of Fibrosis
* Says as soon as provided, patent maturing from this permitted patent
application is anticipated to expire no earlier than June 2035
Source text for Eikon:
Further company coverage:
( Bengaluru Newsroom: +1 -646 -223 -8780).